Development of an in vitro model of human bronchial epithelial barrier to study nanoparticle translocation

Toxicology in Vitro

Volumn 29, Issue 1, 2015, Pages 51-58

  George, Isabelle ^a   Vranic, Sandra ^a   Boland, Sonja ^a   Courtois, Arnaud ^b   Baeza Squiban, Armelle ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

A549; Calu 3; NCI H292; SiO2 nanoparticles; TEER; Transwell filter

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; LUCIFER YELLOW; SILICA NANOPARTICLE; NANOPARTICLE;

ARTICLE; BRONCHUS MUCOSA; CELL TRANSPORT; CELL VIABILITY; CHEMICAL ANALYSIS; CHEMICAL LABELING; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; INTRACELLULAR SPACE; LUNG ALVEOLUS CELL; PERMEABILITY BARRIER; PHYSICAL PARAMETERS; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; BRONCHUS; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; LUNG ALVEOLUS; METABOLISM; RESPIRATORY TRACT MUCOSA; TUMOR CELL LINE;

BRONCHI; CELL LINE; CELL LINE, TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IN VITRO TECHNIQUES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PULMONARY ALVEOLI; RESPIRATORY MUCOSA;

EID: 84924007894     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.08.003     Document Type: Article

References (33)

1. Colvin V.L. The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 2003, 21:1166-1170.
2. Ehrhardt C., Fiegel J., Fuchs S., Abu-Dahab R., Schaefer U.F., Hanes J., Lehr C.M. Drug absorption by the respiratory mucosa: cell culture models and particulate drug carriers. J. Aerosol. Med. 2002, 15:131-139.
3. Florea B.I., Cassara M.L., Junginger H.E., Borchard G. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J. Control Release 2003, 87:131-138.
4. Forbes B., Ehrhardt C. Human respiratory epithelial cell culture for drug delivery applications. Eur. J. Pharm. Biopharm. 2005, 60:193-205.
5. Foster K.A., Avery M.L., Yazdanian M., Audus K.L. Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery. Int. J. Pharm. 2000, 208:1-11.
6. Geiser M., Kreyling W.G. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol. 2010, 7:2.
7. George, I., Vranic, S., Boland, S., Baeza-Squiban, A., 2013. Translocation of SiO2-NPs across in vitro human bronchial epithelial monolayer. vol. Journal of Physics: Conference Series 429, 012022. IOP Publishing.
8. Geys J., Coenegrachts L., Vercammen J., Engelborghs Y., Nemmar A., Nemery B., Hoet P.H. In vitro study of the pulmonary translocation of nanoparticles: a preliminary study. Toxicol. Lett. 2006, 160:218-226.
9. Geys J., Nemery B., Hoet P.H. Optimisation of culture conditions to develop an in vitro pulmonary permeability model. Toxicol. In Vitro 2007, 21:1215-1219.
10. Grainger C.I., Greenwell L.L., Lockley D.J., Martin G.P., Forbes B. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm. Res. 2006, 23:1482-1490.
11. Hagens W.I., Oomen A.G., de Jong W.H., Cassee F.R., Sips A.J. What do we (need to) know about the kinetic properties of nanoparticles in the body?. Regul. Toxicol. Pharmacol. 2007, 49:217-229.
12. Heijink I.H., Brandenburg S.M., Noordhoek J.A., Postma D.S., Slebos D.J., van Oosterhout A.J. Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing. Eur. Respir. J. 2010, 35:894-903.
13. Hoet P.H., Brüske-Hohlfeld I., Salata O.V. Nanoparticles - known and unknown health risks. J. Nanobiotechnol. 2004, 2:12.
14. Lanone S., Rogerieux F., Geys J., Dupont A., Maillot-Marechal E., Boczkowski J., Lacroix G., Hoet P. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part Fibre Toxicol. 2009, 6:14.
15. Lieber M., Smith B., Szakal A., Nelson-Rees W., Todaro G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer 1976, 17:62-70.
16. Madlova M., Jones S.A., Zwerschke I., Ma Y., Hider R.C., Forbes B. Poly(vinyl alcohol) nanoparticle stability in biological media and uptake in respiratory epithelial cell layers in vitro. Eur. J. Pharm. Biopharm. 2009, 72:437-443.
17. Mura S., Hillaireau H., Nicolas J., Kerdine-Römer S., Le Droumaguet B., Deloménie C., Nicolas V., Pallardy M., Tsapis N., Fattal E. Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells. Biomacromolecules 2011, 12:4136-4143.
18. Newland N., Richter A. Agents associated with lung inflammation induce similar responses in NCI-H292 lung epithelial cells. Toxicol. In Vitro 2008, 22:1782-1788.
19. Nowak J.S., Mehn D., Nativo P., García C.P., Gioria S., Ojea-Jiménez I., Gilliland D., Rossi F. Silica nanoparticle uptake induces survival mechanism in A549 cells by the activation of autophagy but not apoptosis. Toxicol. Lett. 2014, 224:84-92.
20. Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
21. Okoturo-Evans O., Dybowska A., Valsami-Jones E., Cupitt J., Gierula M., Boobis A.R., Edwards R.J. Elucidation of toxicity pathways in lung epithelial cells induced by silicon dioxide nanoparticles. PLoS One 2013, 8:e72363.
22. Rodgers L.S., Fanning A.S. Regulation of epithelial permeability by the actin cytoskeleton. Cytoskeleton (Hoboken) 2011, 68:653-660.
23. Schleh C., Semmler-Behnke M., Lipka J., Wenk A., Hirn S., Schäffler M., Schmid G., Simon U., Kreyling W.G. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 2012, 6:36-46.
24. Semmler-Behnke M., Takenaka S., Fertsch S., Wenk A., Seitz J., Mayer P., Oberdörster G., Kreyling W.G. Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ. Health Perspect. 2007, 115:728-733.
25. Semmler-Behnke M., Kreyling W.G., Lipka J., Fertsch S., Wenk A., Takenaka S., Schmid G., Brandau W. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 2008, 4:2108-2111.
26. Simon-Deckers A., Gouget B., Mayne-L'hermite M., Herlin-Boime N., Reynaud C., Carrière M. In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. Toxicology 2008, 253:137-146.
27. Stewart C.E., Torr E.E., Mohd Jamili N.H., Bosquillon C., Sayers I. Evaluation of differentiated human bronchial epithelial cell culture systems for asthma research. J. Allergy (Cairo) 2012, 2012:943982.
28. Tay C.Y., Cai P., Setyawati M.I., Fang W., Tan L.P., Hong C.H., Chen X., Leong D.T. Nanoparticles strengthen intracellular tension and retard cellular migration. Nano Lett. 2014, 14:83-88.
29. van Schilfgaarde M., van Alphen L., Eijk P., Everts V., Dankert J. Parasitosis of Haemophilus influenzae through cell layers of NCI-H292 lung epithelial cells. Infect. Immun. 1995, 63:4729-4737.
30. Vranic S., Boggetto N., Contremoulins V., Mornet S., Reinhardt N., Marano F., Baeza-Squiban A., Boland S. Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry. Part Fibre Toxicol. 2013, 10:2.
31. Vranic S., Garcia-Verdugo I., Darnis C., Sallenave J.M., Boggetto N., Marano F., Boland S., Baeza-Squiban A. Internalization of SiO(2) nanoparticles by alveolar macrophages and lung epithelial cells and its modulation by the lung surfactant substitute Curosurf(®). Environ. Sci. Pollut. Res. Int. 2013.
32. Zheng C., Guo Q., Wu Z., Sun L., Zhang Z., Li C., Zhang X. Amphiphilic glycopolymer nanoparticles as vehicles for nasal delivery of peptides and proteins. Eur. J. Pharm. Sci. 2013, 49:474-482.
33. Zhu Y., Chidekel A., Shaffer T.H. Cultured human airway epithelial cells (calu-3): a model of human respiratory function, structure, and inflammatory responses. Crit. Care Res. Pract. 2010, 1-4.